Cas:690631-97-1 tri(propan-2-yl)-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indol-1-yl]silane manufacturer & supplier

Chemical Name:tri(propan-2-yl)-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indol-1-yl]silane

CAS.NO:690631-97-1

Synonyms:5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(triisopropylsilyl)indole;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(triisopropylsilyl)-1H-indole

Molecular Formula:C₂₃H₃₈BNO₂Si

Molecular Weight:399.45000

HS Code:

Physical and Chemical Properties:

Melting point:107ºC

Boiling point:433.7ºC at 760 mmHg

Density:0.98g/cm3

Index of Refraction:1.505

PSA:23.39000

Exact Mass:399.27600

LogP:5.96410

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(triisopropylsilyl)indole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(triisopropylsilyl)-1H-indole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(triisopropylsilyl)indole Use and application,5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(triisopropylsilyl)indole technical grade,usp/ep/jp grade.

Related News: If an API is not ultrapure, a medicine cannot meet the strict quality criteria so the quality of an API plays a very important role. tri(propan-2-yl)-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indol-1-yl]silane manufacturer South Korea said on Sunday that it would deny entry to any foreigners who have traveled to Wuhan and surrounding Hubei Province in China in the past 14 days. tri(propan-2-yl)-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indol-1-yl]silane supplier A combination of Imbruvica and AbbVie and Roche’s Venclexta slashed the risk of cancer progression or death by 78.4% compared with a cocktail of Roche’s Gazyva and the chemotherapy chlorambucil in previously untreated CLL. The data, from the phase 3 GLOW trial, were shared at the European Hematology Association (EHA) annual meeting. tri(propan-2-yl)-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indol-1-yl]silane vendor If an API is not ultrapure, a medicine cannot meet the strict quality criteria so the quality of an API plays a very important role. tri(propan-2-yl)-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indol-1-yl]silane factory A combination of Imbruvica and AbbVie and Roche’s Venclexta slashed the risk of cancer progression or death by 78.4% compared with a cocktail of Roche’s Gazyva and the chemotherapy chlorambucil in previously untreated CLL. The data, from the phase 3 GLOW trial, were shared at the European Hematology Association (EHA) annual meeting.